IVF-Surrogates of Donated Oocytes

  • Paulo Serafini
  • Jeffrey Nelson
  • Joel Batzofin

Abstract

Parenthood through surrogacy has been used throughout history as a treatment of infertility as noted in both Old and New Testaments.1 Increasing numbers of couples are utilizing surrogate parenting to establish their families.1,2 Utian and associates3 were the first to report in 1985 on a successful in vitro fertilization (IVF)-surrogacy pregnancy in a woman who gestated a genetically unrelated embryo. This form of assisted reproduction appears best described as IVF-surrogacy and this nomenclature will be used hereafter.

Keywords

Hepatitis Insurance Coverage Heparin Flare Expense 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Serafini P, Tran C, Richardson A, et al. In vitro fertilization surrogacy. Assist Reprod Rev. 1994; 4: 155–161.Google Scholar
  2. 2.
    American Fertility Society. Surrogate gestational mothers: women who gestate genetically unrelated embryos. In Ethical considerations of the new reproductive technologies. Fertil Steril. 1990; 53(6): suppl 2, chap 21, 64S.Google Scholar
  3. 3.
    Utian WH, Sheean L, Godfarb JM, et al. Successful pregnancy after in vitro fertilization-embryo transfer from an infertile woman to a surrogate. N Engl J Med. 1985; 313: 1351–1352.PubMedGoogle Scholar
  4. 4.
    The American Fertility Society. Guidelines for gamete donation. Fertil Steril. 1993; 59(2): 15–45.Google Scholar
  5. 5.
    Serhal P. Oocyte donation and surrogacy. Br Med Bull. 1990; 46: 796–812.PubMedGoogle Scholar
  6. 6.
    Serafini P, Nelson J, Smith SB, et al. Oocyte donation: quality control issues. In: New ways of making babies: the case of egg donation, Cynthia B. Cohen, ed. National Board in Ethics and Reproduction. Indiana University Press, 1996.Google Scholar
  7. 7.
    Sauer MV, Paulson R. Human oocyte and pre-embryo donation: an evolving method for the treatment of infertility. Am J Obstet Gynecol. 1990; 163: 1421–1424.PubMedGoogle Scholar
  8. 8.
    Pados G, Camus M, Van Waesberghe L, et al. Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum Reprod. 1994; 7: 1111–1117.Google Scholar
  9. 9.
    Zegers-Hochslchild F, Fernandez E, Fabres C, et al. Pregnancy rate in an oocyte donation program. J Assist Reprod Genet. 1992; 9: 350–352.CrossRefGoogle Scholar
  10. 10.
    Feinman M, Sher G, Massaranni G, et al. High fecundity rates in donor oocyte recipients and in-vitro fertilization surrogates using parenteral oestradiol valerate. Hum Reprod. 1993; 8: 1145–1147.PubMedGoogle Scholar
  11. 11.
    Serafini P, Nelson J, Batzofin J. Pregnancy and menopause: how safe it really is. Revista Iberoamericana Fertilidad. 1996; 45–50.Google Scholar
  12. 12.
    Sauer MV, Paulson RJ, Lobo RA. Pregnancy after age 50: application of oocyte donation to women after the natural menopause. Lancet. 1993; 341: 321–323.PubMedCrossRefGoogle Scholar
  13. 13.
    Antinori S, Versaci C, Panci C, et al. Fetal and maternal mortality in menopausal women aged 45–63 years. Hum Reprod. 1995; 464–469.Google Scholar
  14. 14.
    Jones HW Jr. Reconstruction of congenital uterovaginal anomalies. In: Rock JA, Murphy AA, Jones HW Jr, eds. Female Reproductive Surgery. Baltimore: Williams & Wilkins; 1992: 246–286.Google Scholar
  15. 15.
    Nagel TC, Malo JW. Hysteroscopic metroplasty in the diethylstilbestrol-exposed uterus and similar nonfusion anomalies: effects on subsequent reproductive performance; a preliminary report. Fertil Steril. 1993; 59: 502–506.PubMedGoogle Scholar
  16. 16.
    Fraser EJ, Grimes DA, Schulz KF. Immunization as therapy for recurrent spontaneous abortion: a review and meta-analysis. Obstet Gynecol. 1993; 82: 854–859.PubMedGoogle Scholar
  17. 17.
    Silver RM, Branch DW. Should you treat women who have antiphospholipid syndrome? Contemp Ob/Gyn. 1994; 39: 63–83.Google Scholar
  18. 18.
    Cunningham FG. Connective-tissue disorders complicating pregnancy. In: Cunningham FG, MacDonald PC, Gant NF, eds. Williams Obstetrics. 18th ed. New York: Appleton-Century-Crofts; 1993: suppl 22.Google Scholar
  19. 19.
    Harvey JC, Rosen PP, Ashikari R. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy. Surg Gynecol Obstet. 1981; 153: 723–725.PubMedGoogle Scholar
  20. 20.
    Danforth DN Jr. How subsequent pregnancy affects outcome in women with a prior breast cancer. Oncology. 1991; 5: 23–31.PubMedGoogle Scholar
  21. 21.
    Frydman R, Letur-Konirsch H, de Ziegler D, et al. A protocol for satisfying the ethical issues raised by oocyte donation: the free, anonymous, and fertile donors. Fertil Steril. 1990; 53: 666–672.PubMedGoogle Scholar
  22. 22.
    Cha KY, Koo JJ, Ko JJ, et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril. 1993; 55: 109–113.Google Scholar
  23. 23.
    Seibel MM. Cadaveric ovary donation. In: Seibel MM, Crockin SL, eds. Family Building through Egg and Sperm Donation. Medical, Legal, and Ethical Issues. Sudbury: Jones & Bartlett; 1996: 30.Google Scholar
  24. 24.
    Colmorgen GHC, Johnson C, Zazzarino MA, et al. Routine urine drug screening at the first prenatal visit. Am J Obstet Gynecol. 1992; 166: 588.PubMedGoogle Scholar
  25. 25.
    Balmaceda JP, Alam V, Roszjtein D, et al. Embryo implantation rates in oocyte donation: a prospective comparison of tubal versus uterine transfers. Fertil Steril. 1992; 57: 362–365.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Paulo Serafini
  • Jeffrey Nelson
  • Joel Batzofin

There are no affiliations available

Personalised recommendations